Official BRACELET-1 trial results indicate that adding the oncolytic virus immunotherapy pelareorep to paclitaxel chemotherapy warrants further investigation in HR+ HER2- metastatic breast cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-Sep-2025 09:11 ET (23-Sep-2025 13:11 GMT/UTC)